Results of neoadjuvant chemotherapy and radiation therapy in the breast‐conserving treatment of 250 patients with all stages of infiltrative breast cancer
暂无分享,去创建一个
C. Jacquillat | M. Weil | F. Baillet | C. Borel | G. Auclerc | M. A. de Maublanc | M. Housset | G. Forget | L. Thill | C. Soubrane | D. Khayat | MD' D CLAUDE JACQUILLAT | MD Marise Weil | MD Franqois Baillet | MD Christian Borel | MD G6rard Auclerc | MD M. A. de Maublanc | MD Martin Housset | PhM Genevihve Forget | MD Laurence Thill | MD Claude Soubrane | MD David Khayat
[1] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[2] F. Baclesse. Five‐Year Results in 431 Breast Cancers Treated Solely by Roentgen Rays , 1965, Annals of surgery.
[3] P. Denoix. The Institut’s Contribution to the Definition of Factors Guiding the Choice of Treatment , 1970 .
[4] D. Cox. Regression Models and Life-Tables , 1972 .
[5] J. Peto,et al. Asymptotically Efficient Rank Invariant Test Procedures , 1972 .
[6] C. Redmond,et al. 1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. , 1975, The New England journal of medicine.
[7] G. Bonadonna,et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. , 1976, The New England journal of medicine.
[8] B. Fisher,et al. The evolution of breast cancer surgery: past, present, and future. , 1978, Seminars in Oncology.
[9] P. Schlienger,et al. Conservative management of operable breast cancer. Ten years experience at the Foundation Curie , 1978, Cancer.
[10] R. Nissen-Meyer,et al. Surgical adjuvant chemotherapy. Results with one short course with cyclophosphamide after mastectomy for breast cancer , 1978, Cancer.
[11] J. Holland,et al. Adjuvant chemotherapy of breast cancer , 1979, Cancer.
[12] R. K. Knight,et al. Combined chemotherapy and radiotherapy for locally advanced breast cancer. , 1980, European journal of cancer.
[13] A. Miller,et al. Reporting results of cancer treatment , 1981, Cancer.
[14] G. Bonadonna,et al. Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgery. , 1981, Cancer clinical trials.
[15] A. Luini,et al. Comparing Radical Mastectomy with Quadrantectomy, Axillary Dissection, and Radiotherapy in Patients with Small Cancers of the Breast , 1981 .
[16] Concurrent chemotherapy and radiotherapy for nonmetastatic, Stage IV breast cancer: A pilot study by the Southeastern Cancer Study Group , 1983, American journal of clinical oncology.
[17] T. Pajak,et al. The effect of adjuvant chemotherapy on cosmesis and complications in patients with breast cancer treated by definitive irradiation. , 1983, International journal of radiation oncology, biology, physics.
[18] P. Antich,et al. An analysis of the role of radiotherapy alone and in combination with chemotherapy and surgery in the management of advanced breast carcinoma , 1983, Cancer.
[19] G. Hortobagyi,et al. The management of locally advanced breast cancer: a combined modality approach. , 1984, European journal of cancer & clinical oncology.
[20] Frcr,et al. Breast conservation in the treatment of early breast cancer a 20‐year follow‐up , 1984, Cancer.
[21] H. Bingham. Breast conservation in the treatment of early breast cancer , 1984 .
[22] C. Hill,et al. Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less the experience of the institut gustave‐roussy , 1984, Cancer.
[23] A. Dritschilo,et al. Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] D. Sarrazin. Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less , 1985 .
[25] B Fisher,et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. , 1985, The New England journal of medicine.
[26] E. Engelsman,et al. Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study. , 1985, International journal of radiation oncology, biology, physics.
[27] R. Gelber,et al. Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies. , 1986, NCI monographs : a publication of the National Cancer Institute.
[28] C. Redmond,et al. Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] S. Friedman,et al. Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] M. Namer,et al. Conservative treatment (chemotherapy/radiotherapy) of locally advanced breast cancer , 1986, Cancer.
[31] S. Steinberg,et al. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. , 1987, Cancer research.
[32] L. Holsti,et al. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. II. 5‐year results and influence of levamisole , 1987, Cancer.
[33] Jack Cuzick,et al. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women , 1988 .
[34] C. Jacquillat,et al. Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced breast cancer (IIIA‐IIIB) , 1988, Cancer.
[35] R. Gray,et al. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] G. Hortobagyi,et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy , 1988, Cancer.
[37] Devita Vt. On the value of response criteria in therapeutic research. , 1988 .
[38] G. Bonadonna,et al. The contribution of medicine to the primary treatment of breast cancer. , 1988, Cancer research.
[39] M. Zelen,et al. Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. , 1989, The New England journal of medicine.
[40] C K Osborne,et al. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. , 1989, The New England journal of medicine.
[41] W. Hryniuk. Correlation of dose intensity and prognosis in adjuvant chemotherapy: an extended controversy. , 1989, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[42] H. Bartelink,et al. Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792). , 1989, European journal of cancer & clinical oncology.
[43] C. Redmond,et al. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. , 1989, The New England journal of medicine.